Clin Exp Otorhinolaryngol.  2015 Sep;8(3):206-210. 10.3342/ceo.2015.8.3.206.

Outcomes of Severe to Profound Idiopathic Sudden Sensorineural Hearing Loss

Affiliations
  • 1Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Hospital, Gwangju, Korea. entcnuh@gmail.com

Abstract


OBJECTIVES
While a severe to profound sudden sensorineural hearing loss (SSNHL) may cause serious disability in verbal communication, there have been little studies focusing on this high degree SSNHL. The present study was aimed to investigate the characteristics of hearing recovery in a high degree SSNHL (>70 dB).
METHODS
Three hundred and two SSNHL patients were enrolled. For a long-term follow-up, 46 patients were evaluated. Hearing level was examined by pure tone audiometry on day 1, week 3, month 3, month 6, and year 1 or after. According to the degree of the initial hearing loss, the patients were divided into 4 groups from 70 to > or =100 dB.
RESULTS
After 3 weeks, the recovery rate and mean hearing gain was 61%, 23.85 dB in the 70 dB group, whereas 10%, 6.61 dB in the > or =100 dB group. There was a significant correlation between 3-week recovery and final hearing outcome. However, there was almost no recovery after 3 months.
CONCLUSION
An early recovery can be a prognostic factor for the final recovery in severe to profound SSNHL. Since recovery after 3 months is rare, an early hearing intervention like hearing aid or cochlear implantation should be considered in the high degree SSNHL to restore the patient's verbal communication.

Keyword

Hearing Loss, Sudden; Treatment Outcome; Ear, Inner; Cochlea

MeSH Terms

Audiometry
Cochlea
Cochlear Implantation
Cochlear Implants
Ear, Inner
Follow-Up Studies
Hearing
Hearing Aids
Hearing Loss
Hearing Loss, Sensorineural*
Hearing Loss, Sudden
Humans
Treatment Outcome

Figure

  • Fig. 1 Recovery time among four groups according to the changes in average hearing levels by pure tone audiographic measurement. Note that, the initial 3 weeks showed the highest recovery rate, 3 weeks to 3 months demonstrated slight recovery but no improvement was noted after 3 months. 70 dB group, n=10; 80 dB group, n=11; 90 dB group, n=16; ≥100 dB group, n=9.

  • Fig. 2 Comparison of initial 3-week hearing recovery rates among the 70 dB group, 80 dB group, 90 dB group, and ≥100 dB group. The degrees of recovery for comparison were complete, partial, slight recovery according to Siegel's criteria. Overall recovery is the sum of complete recovery, partial recovery, slight improvement. Analysis of variance with Bonferroni correction (*P<0.05).

  • Fig. 3 Comparison of hearing gain during initial 3-week period among the 70 dB group, 80 dB group, 90 dB group, and ≥100 dB group. Note that in the 70 dB group, there cannot be a gain value exceeding 70 dB. The degree of hearing gain is lower in the highest grade hearing loss group.


Cited by  1 articles

3D FLAIR Cochlear Abnormality Does Not Predict on Sudden Sensorineural Hearing Loss Prognosis: A Retrospective Cohort Study
Geun Cheol Shin, Ara Cho, Min Cheol Jeong, Beom Seok Sohn, Seong Hoon Bae
Korean J Otorhinolaryngol-Head Neck Surg. 2022;65(3):143-149.    doi: 10.3342/kjorl-hns.2021.00409.


Reference

1. De Kleyn A. Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Otolaryngol. 1944; 1. 32(5-6):407–429.
2. Byl FM Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope. 1984; 5. 94(5 Pt 1):647–661. PMID: 6325838.
3. Cvorovic L, Deric D, Probst R, Hegemann S. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008; 6. 29(4):464–469. PMID: 18434930.
4. Jun HJ, Chang J, Im GJ, Kwon SY, Jung H, Choi J. Analysis of frequency loss as a prognostic factor in idiopathic sensorineural hearing loss. Acta Otolaryngol. 2012; 6. 132(6):590–596. PMID: 22497556.
Article
5. Ceylan A, Celenk F, Kemaloglu YK, Bayazit YA, Goksu N, Ozbilen S. Impact of prognostic factors on recovery from sudden hearing loss. J Laryngol Otol. 2007; 11. 121(11):1035–1040. PMID: 17241495.
Article
6. Narozny W, Kuczkowski J, Kot J, Stankiewicz C, Sicko Z, Mikaszewski B. Prognostic factors in sudden sensorineural hearing loss: our experience and a review of the literature. Ann Otol Rhinol Laryngol. 2006; 7. 115(7):553–558. PMID: 16900810.
Article
7. Hong SM, Ko YG, Park CH, Lee JH, Kim JH. Analysis of hearing improvement in patients with severe to profound sudden sensorineural hearing loss according to the level of pure tone hearing threshold. Eur Arch Otorhinolaryngol. 2012; 9. 269(9):2057–2060. PMID: 22143582.
Article
8. Lee SS, Cho HH, Jang CH, Cho YB. Fate of sudden deafness occurring in the only hearing ear: outcomes and timing to consider cochlear implantation. J Korean Med Sci. 2010; 2. 25(2):283–286. PMID: 20119584.
Article
9. Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am. 1975; 6. 8(2):467–473. PMID: 1153209.
Article
10. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch Otolaryngol. 1980; 12. 106(12):772–776. PMID: 7002129.
Article
11. Sheehy JL. Vasodilator therapy in sensory-neural hearing loss. Laryngoscope. 1960; 7. 70:885–914. PMID: 14445724.
Article
12. Byl FM. Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope. 1977; 5. 87(5 Pt 1):817–825. PMID: 850455.
Article
13. Liu SC, Kang BH, Lee JC, Lin YS, Huang KL, Liu DW, et al. Comparison of therapeutic results in sudden sensorineural hearing loss with/without additional hyperbaric oxygen therapy: a retrospective review of 465 audiologically controlled cases. Clin Otolaryngol. 2011; 4. 36(2):121–128. PMID: 21414179.
Article
14. Ito S, Fuse T, Yokota M, Watanabe T, Inamura K, Gon S, et al. Prognosis is predicted by early hearing improvement in patients with idiopathic sudden sensorineural hearing loss. Clin Otolaryngol Allied Sci. 2002; 12. 27(6):501–504. PMID: 12472519.
Article
Full Text Links
  • CEO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr